These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 35686902)

  • 1. Molecular study of recent virus and its relationship to Pityriasis rosea.
    Kawen AA
    J Popul Ther Clin Pharmacol; 2022; 29(1):e109-e115. PubMed ID: 35686902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pityriasis Rosea after COVID-19 Infection.
    Prtajin M; Ljubojević Hadžavdić S
    Acta Dermatovenerol Croat; 2022 Dec; 30(4):265-266. PubMed ID: 36919396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination.
    Drago F; Broccolo F; Ciccarese G
    Clin Dermatol; 2022; 40(5):586-590. PubMed ID: 35093476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of COVID-19 on Clinicopathological Spectrum of Pityriasis Rosea in Korea.
    Kim DH; Cho JH; Park SJ; Seo SH; Ahn HH
    J Korean Med Sci; 2022 Jun; 37(24):e190. PubMed ID: 35726143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease.
    Dursun R; Temiz SA
    Dermatol Ther; 2020 Jul; 33(4):e13730. PubMed ID: 32475003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronavirus disease 2019 and pityriasis rosea: A review of the immunological connection.
    Borgia F; Li Pomi F; Alessandrello C; Vaccaro M; Pioggia G; Gangemi S
    J Dermatol; 2022 Oct; 49(10):948-956. PubMed ID: 35675487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pityriasis rosea Gibert triggered by SARS-CoV-2 infection: A case report.
    Birlutiu V; Birlutiu RM; Iancu GM
    Medicine (Baltimore); 2021 Apr; 100(14):e25352. PubMed ID: 33832113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine.
    Cohen OG; Clark AK; Milbar H; Tarlow M
    Hum Vaccin Immunother; 2021 Nov; 17(11):4097-4098. PubMed ID: 34435935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature.
    Buckley JE; Landis LN; Rapini RP
    JAAD Int; 2022 Jun; 7():164-168. PubMed ID: 35156062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of Pityriasis Rosea in Relation to SARS-CoV-2/COVID-19 Infection and Vaccination.
    Wong N; Cascardo CA; Mansour M; Qian V; Potts GA
    Cureus; 2023 May; 15(5):e38772. PubMed ID: 37303403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary occurrence of Chilblain-like lesions and Pityriasis rosea during the COVID-19 pandemic.
    Piccolo V; Bassi A; Argenziano G; Mazzatenta C; Cutrone M; Neri I; Grimalt R; Russo T
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e619-e620. PubMed ID: 34050995
    [No Abstract]   [Full Text] [Related]  

  • 12. Manifestation of pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccine: A systematic review.
    Khan I; Elsanousi AA; Shareef AM; Tebha SS; Arif A; Gul S
    Immun Inflamm Dis; 2023 Apr; 11(4):e804. PubMed ID: 37102660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
    Hoşgelen EI; Alptekin K
    Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34750798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
    Hoşgelen EI; Alptekin K
    Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34637131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine.
    Valk B; Bender B
    Cutis; 2021 Dec; 108(6):317-318. PubMed ID: 35167784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: Case report and brief literature review.
    Pedrazini MC; da Silva MH
    Dermatol Ther; 2021 Nov; 34(6):e15129. PubMed ID: 34533265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of SARS-CoV-2 PCR Positive Cases in the Pediatric Emergency Department].
    Şık N; Özlü C; Karaoğlu Asrak H; Erbaş İC; Çakıl Güzin A; Atakul G; Atay Ö; Appak Ö; Sayıner AA; Uzuner N; Asilsoy S; Belet N; Yılmaz D; Duman M
    Mikrobiyol Bul; 2020 Oct; 54(4):629-637. PubMed ID: 33107292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review.
    Avallone G; Quaglino P; Cavallo F; Roccuzzo G; Ribero S; Zalaudek I; Conforti C
    Int J Dermatol; 2022 Oct; 61(10):1187-1204. PubMed ID: 35141881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review.
    Wang CS; Chen HH; Liu SH
    J Formos Med Assoc; 2022 May; 121(5):1003-1007. PubMed ID: 35012825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous manifestations of COVID-19.
    Wang CJ; Worswick S
    Dermatol Online J; 2021 Jan; 27(1):. PubMed ID: 33560783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.